A model that most accurately recapitulates the in vivo disease state is an essential part of any clinical or research investigator’s repertoire to better understand the pathogenesis and develop potential therapeutics.
Leading virologist at Mount Sinai, Dr. Benjamin tenOever, developed a series of human lung cell models for coronavirus screening to better understand immune responses to the disease and co-authored the study.
At a laboratory in Manhattan, researchers have discovered how SARS-CoV-2 uses our defenses against us.
Amodiaquine, a related treatment for malaria, can beat back Covid-19 in hamsters. But if this drug, too, gets overhyped, there will be awful consequences.
New York Times. A small study of an inhaled form of a commonly available drug, interferon beta, suggests it could reduce the odds of patients becoming severely ill.
Science Magazine. The results of clinical trials from Synairgen suggest that IFN-I can reduce the severity of COVID-19.